Brought to you by 
Orexo buys fellow Swedish company Biolipox for SEK803mm
23 Oct 2007
Executive Summary
Drug delivery company Orexo AB is issuing 8.56mm of its shares to acquire Biolipox AB (anti-inflammatory drug candidates) in a deal worth SEK803mm ($125mm) based on Orexo's ten-day average prior to deal announcement.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Orexo buys fellow Swedish company Biolipox for SEK803mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice